No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Micro-Tech (Nanjing) Co., Ltd. is a key manufacturer and global supplier of non-vascular stents and disposable biopsy forceps. The company's primary markets span China, Europe, North America, and Oceania. Its extensive product portfolio includes specialized gastroenterology devices such as longwire and shortwire biliary stents, biopsy instruments, dilation and hemostasis products, EUS tools, nitinol stents, resection devices, retrieval systems, and related accessories. For pulmonology, offerings comprise airway stents, biopsy tools, dilation balloons, cytology brushes, retrieval devices, and additional accessories. Beyond its own product lines, Micro-Tech also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services to other medical device firms. Founded in 1999, the company is headquartered in Nanjing, China.
www.micro-tech.com.cnNo one on the platform currently holds 688029.SS.
No tracked institution reports a position in 688029.SS as of their last filing.
No one on the platform has traded 688029.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 17.2% | 21.4% | — | — | — | |
| Rev. Growth % | 14.9% | 19.0% | ||||
| Profit Margin % | 18.0% | 18.3% | 16.2% | |||
| Free Cash Flow Margin % | 13.7% | 8.5% | 10.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.5B | +9.1% | $3.11 | $3.10–$3.12 | — | 3 |
| 2027 | $4.0B | +13.9% | $3.73 | $3.73–$3.74 | — | 3 |
| 2028 | $4.6B | +15.2% | $4.50 | $3.99–$4.86 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-02-24 | $0.59 | $0.55 | -7.5% |
| 2024-10-29 | $0.80 | $0.75 | -6.1% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 688029.SSMicro-Tech (Nanjing) Co., Ltd. | $81.59 | +3.20% | $15.2B | — |
| 000403.SZPacific Shuanglin Bio-pharmacy Co., Ltd. | $9.95 | -0.50% | $9.5B | — |
| 002020.SZZhejiang Jingxin Pharmaceutical Co., Ltd. | $11.33 | -1.13% | $9.8B | — |
| 002432.SZAndon Health Co., Ltd. | $59.63 | +0.45% | $27.8B | — |
| 300171.SZTofflon Science and Technology Group Co., Ltd. |
| $13.66 |
| -0.65% |
| $10.4B |
| — |
| 300529.SZJafron Biomedical Co.,Ltd. | $14.77 | -0.61% | $11.8B | — |
| 300573.SZShenyang Xingqi Pharmaceutical Co.,Ltd | $36.21 | +0.30% | $12.9B | — |
Source: Financial Modeling Prep · peers by sector/industry